The chart below shows how LNTH performed 10 days before and after its earnings report, based on data from the past quarters. Typically, LNTH sees a +0.69% change in stock price 10 days leading up to the earnings, and a +0.41% change 10 days following the report. On the earnings day itself, the stock moves by +2.86%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Third Quarter Revenue Increase: Consolidated net revenue for the third quarter was $378.7 million, an increase of 18.4%.
Radiopharmaceutical Sales Increase: Radiopharmaceutical oncology contributed $259.8 million of sales attributable to PYLARIFY, which was up 20.6%.
Quarterly Operating Profit Increase: Operating profit for the quarter was $165.1 million, an increase of 18.3%.
Net Income Increase: Net income for the third quarter was $131 million and $124.1 million on an adjusted basis, an increase of 20.4%.
Operating Cash Flow Increase: Third quarter operating cash flow totaled $175.1 million, $58.3 million over prior year.
Negative
Quarterly Net Sales Performance: Net sales for the quarter were approximately $260 million, up 20% year-over-year and down 5% sequentially.
Revenue Decline Factors: The sequential revenue decline was driven by traditional third quarter seasonality, the net price impact of our recently secured strategic partnerships as well as intentional trade-offs largely due to product availability.
Increased Operating Expenses: Operating expenses at 24.6% of net revenue or 111 basis points higher than the prior year rate with a focus on increased R&D investment in support of our early- and late-stage assets.
Quarterly Financial Adjustments: Total adjustments in the quarter were $6 million of gain before taxes of this amount, $20.4 million and $11.9 million of expense is associated with non-cash stock and incentive plans and acquired intangible amortization, respectively.
Effective Tax Rate Analysis: Our effective tax rate was 27.1%.
Lantheus Holdings, Inc. (LNTH) Q3 2024 Earnings Call Transcript
LNTH.O
-3.23%